The Barrow Neurological Institute is proud of its reputation as a medical research facility and is home to some of the most sophisticated research programs outside of an academic setting in the Southwestern United States. Researchers in the Barrow Neurosurgery Research Center are devoted to learning more about the causes of and treatments for a wide range of disorders, such as stroke, aneurysms, spinal cord injury, and hydrocephalus. Our research has led to treatments that are being used around the world. Within the Department are neurosurgeons who subspecialize in cerebrovascular and skull base, functional and stereotactic, pediatric, spine, tumor, and endovascular neurosurgery.
Physicians, scientists, and expert clinical staff come together with a commitment to developing new techniques for the prevention, diagnosis, treatment, and rehabilitation of neurological illnesses and injuries. The leadership of internationally respected physicians keeps Barrow at the forefront of neuroscience. The compassionate expertise of its extensive staff of nurses, technologists, therapists and support personnel is evident in every aspect of care provided.
Our mission is to advance the knowledge and practice of medicine in neuroscience through basic and clinical research, education of medical professionals, and innovation in clinical techniques and technology.
Submissions from 1995
Magnetic resonance imaging in patients with low-tension glaucoma, G A. Stroman, W C. Stewart, K C. Golnik, J K. Curé, and R E. Olinger
Anticoagulation for prevention of cerebral infarcts following subarachnoid hemorrhage, D Z. Wang, N Futrell, C Taylon, and C Millikan
Crying seizures after cerebral infarction, D Z. Wang, R E. Steg, and N Futrell
A reproducible model of middle cerebral infarcts, compatible with long-term survival, in aged rats, L C. Wang, N Futrell, D Z. Wang, F J. Chen, Q H. Zhai, and L R. Schultz
Orbital infarction syndrome after surgery for intracranial aneurysms, C F. Zimmerman, P D. Van Patten, K C. Golnik, T A. Kopitnik, and R Anand
Submissions from 1994
Fluctuating Parkinson's Disease: Treatment With the Eong-Acting Dopamine Agonist Cabergoline, J. Eric Ahlskog, Manfred D. Muenter, Demetrius M. Maraganore, Joseph Y. Matsumoto, Abraham N. Lieberman, Kathy F. Wright, and Kay Wheeler
Ophthalmic manifestations of Rochalimaea species, K C. Golnik, M E. Marotto, M M. Fanous, D Heitter, L P. King, J I. Halpern, and P H. Holley
Folate-responsive optic neuropathy, K C. Golnik and E R. Schaible
Laughter and crying in neurologic disorders, Aziz Taher Shaibani, Marwan N. Sabbagh, and Rachelle Doody
Horner's syndrome after tonsillectomy, C G. Shissias and K C. Golnik
Submissions from 1993
Temporal Dissociation of the Prehension Pattern in Parkinson's Disease, Umberto Castiello, George E. Stelmach, and Abraham N. Lieberman
Treatment of Advanced Parkinson's Disease, Abraham N. Lieberman
Combined obstruction of the central retinal artery and vein associated with meningeal carcinomatosis, E R. Schaible and K C. Golnik
Submissions from 1992
The Role of the Regulatory Enzymes of Catecholamine Synthesis in Parkinson's Disease, Menek Goldstein and Abraham N. Lieberman
Diagnosis of cavernous sinus arteriovenous fistula by measurement of ocular pulse amplitude, K C. Golnik and N R. Miller
Familial recurrent cranial nerve palsy, K C. Golnik and N R. Miller
Rate of progression and severity of neuro-ophthalmologic manifestations of cavernous sinus meningiomas, K C. Golnik, N R. Miller, and D M. Long
Dopamine Agonists Used as Monotherapy in De Novo PD Patients: Comparisons With Selegiline, Abraham N. Lieberman
Emerging Perspectives in Parkinson's Disease, Abraham N. Lieberman
Long-Term Experience With Selegiline and Levodopa in Parkinson's Disease, Abraham N. Lieberman
Ophthalmic involvement in myo-neuro-gastrointestinal encephalopathy syndrome, A B. Threlkeld, N R. Miller, K C. Golnik, J W. Griffin, R W. Kuncl, D R. Johns, M Lehar, and O Hurko
Submissions from 1991
Late recovery of function after oculomotor nerve palsy, K C. Golnik and N R. Miller
Angle-closure glaucoma consequent to embolization of dural cavernous sinus fistula, K C. Golnik, S A. Newman, and R Ferguson
Cryptococcal optic neuropathy in the acquired immune deficiency syndrome, K C. Golnik, S A. Newman, and B Wispelway
Experience With Selegiline and Levodopa in Advanced Parkinson's Disease, Abraham N. Lieberman and E. Fazzini
Submissions from 1990
Anterior ischemic optic neuropathy associated with macrocytic anemia, K C. Golnik and S A. Newman
Randomized Double-Blind Cross-Over Study of Sinemet-Controlled Release (CR4 50/200) Versus Sinemet 25/100 in Parkinson's Disease, Abraham N. Lieberman, Govindan Gopinathan, Edith Miller, Andreas Neophytides, Greg Baumann, and Linda Chin
Submissions from 1989
Adrenal Medullary Transplants as a Treatment for Advanced Parkinson's Disease, Abraham N. Lieberman, J. Ransohoff, P. Berczeller, P. Brous, K. Eng, M. Goldstein, B. Kaufman, M. Koslow, and L. Chin
Submissions from 1983
Spectroscopic and kinetics studies of the inhibition of pig kidney diamine oxidase by anions, D M. Dooley and K C. Golnik